Bi-Specific Fusion Proteins
US-2024101713-A1 · Mar 28, 2024 · US
Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2 · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/65 |
| Official title | Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2 |
| Display label | Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2 |
| Total patents | 259 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 19 |
| 2016 | 30 |
| 2017 | 35 |
| 2018 | 23 |
| 2019 | 23 |
| 2020 | 23 |
| 2021 | 23 |
| 2022 | 19 |
| 2023 | 19 |
| 2024 | 18 |
| 2025 | 20 |
| 2026 | 7 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
US-9845346-B2 · Dec 19, 2017 · US
Cartilage-binding fusion proteins
US-2017327556-A1 · Nov 16, 2017 · US
Systems and methods for determining therapeutic uptake and dosing
US-2017328886-A1 · Nov 16, 2017 · US
Nucleic acid constructs including a txnip promoter for the treatment of disease
US-2017252376-A1 · Sep 7, 2017 · US
Parathyroid hormone, insulin, and related peptides conjugated to bone targeting moieties and methods and making and using thereof
US-9718868-B2 · Aug 1, 2017 · US
Selective cartilage therapy
US-9637531-B2 · May 2, 2017 · US
Expression of the human IGF-1 in transgenic plastids
US-9605045-B2 · Mar 28, 2017 · US
IGF-I poly (ethylene glycol) conjugates
US-9587006-B2 · Mar 7, 2017 · US
Targeted therapeutics
US-2017015726-A1 · Jan 19, 2017 · US
Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases
US-9545450-B2 · Jan 17, 2017 · US
Reporter of genomic methylation and uses thereof
US-2016340749-A1 · Nov 24, 2016 · US
Purification of non-glycosylated polypeptides
US-9481706-B2 · Nov 1, 2016 · US
Lysosomal targeting peptides and uses thereof
US-9469683-B2 · Oct 18, 2016 · US
Targeted therapeutics
US-9421245-B2 · Aug 23, 2016 · US
Targeted/immunomodulatory fusion proteins and methods for making same
US-2016237155-A1 · Aug 18, 2016 · US
Efficient production of peptides
US-2016208304-A1 · Jul 21, 2016 · US
Poultry performance
US-9394515-B2 · Jul 19, 2016 · US
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
US-9376480-B2 · Jun 28, 2016 · US
Targeted/immunomodulatory fusion proteins and methods for making same
US-2016168260-A1 · Jun 16, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/65?
- CPC C07K14/65 is the Cooperative Patent Classification code for “Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2.”
- How many patents are filed under CPC C07K14/65 (Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2)?
- Our database includes 259 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/65 growing?
- Publication counts under this code: 18 in 2024 vs 20 in 2025 (latest complete years).